All lobbying filings

THE MCMANUS GROUP

Lobbying for ACESSO BIOLOGICS · Biologics Company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Nevada · House · Senate · $50,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

S 2561
Skin Substitute Access and Payment Reform Act of 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to coverage of and reimbursement for Human Cell & Tissue products, including Local Coverage Determination L39764- Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers. Skin Substitute Access and Payment Reform Act of 2025 (S. 2561). Issues related to skin substitute payment in 2026 Physician Fee Schedule Proposed Rule (CMS-1832-P).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.